# Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC

> **NCT03778138** · PHASE2 · UNKNOWN · sponsor: **Henan Provincial People's Hospital** · enrollment: 51 (estimated)

## Conditions studied

- Non-squamous Cell Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Anlotinib plus Pemetrexed

## Key facts

- **NCT ID:** NCT03778138
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778138, "Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03778138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*